Legal Representation
Attorney
Erica Halstead
USPTO Deadlines
Next Deadline
1652 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-02-06)
Due Date
February 06, 2030
Grace Period Ends
August 06, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
29 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jun 17, 2024 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
May 13, 2024 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
May 13, 2024 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
May 6, 2024 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
Feb 6, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
Feb 6, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Nov 27, 2023 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
Nov 21, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Nov 21, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Nov 1, 2023 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
Nov 1, 2023 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
Nov 1, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Oct 13, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Oct 3, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Oct 3, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Oct 3, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Sep 2, 2023 | ATRV | O | ATTORNEY REVIEW COMPLETED | Loading... |
Aug 14, 2023 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
Jul 24, 2023 | RNWL | P | INTERNATIONAL REGISTRATION RENEWED | Loading... |
Jul 24, 2023 | CREV | I | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | Loading... |
Jul 14, 2023 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
Jul 14, 2023 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
Jul 12, 2023 | CRCV | M | CORRECTION TRANSACTION RECEIVED FROM IB | Loading... |
Jun 8, 2023 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
Jun 7, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
May 25, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
May 23, 2023 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
May 19, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
May 18, 2023 | SDRC | M | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases of the circulatory system and diabetes-related diseases, pharmaceutical preparations for treatment of fatty liver and steatohepatitis, pharmaceutical preparations for the treatment of cardiovascular disorders and metabolic disorders, pharmaceutical preparations for the treatment of digestive system disease, pharmaceutical preparations for the treatment of primary biliary cirrhosis, pharmaceutical preparations for the treatment of fatty liver and liver hepatitis and liver cirrhosis, pharmaceutical preparations for the treatment of liver disease, pharmaceutical preparations for the treatment of metabolic disease, pharmaceutical preparations for the prevention and treatment of disorders of the metabolic system, analgesics; pharmaceutical and biological preparations for the treatment of diseases of the central nervous system, peripheral nervous system, sensory organs, the circulatory system, respiratory system, and the digestive system; pharmaceutical substances for the treatment of dermatological diseases, allergies and urogenital or anal conditions; veterinary preparations, namely, veterinary preparations for the treatment of diseases of the circulatory system and diabetes-related diseases, veterinary preparations for treatment of fatty liver and steatohepatitis, veterinary preparations for the treatment of cardiovascular disorders and metabolic disorders, veterinary preparations for the treatment of digestive system disease, veterinary preparations for the treatment of primary biliary cirrhosis, veterinary preparations for the treatment of fatty liver and liver hepatitis and liver cirrhosis, veterinary preparations for the treatment of liver disease, veterinary preparations for the treatment of metabolic disease, veterinary preparations for the prevention and treatment of disorders of the metabolic system, analgesics; veterinary pharmaceutical and biological preparations for the treatment of diseases of the central nervous system, peripheral nervous system, sensory organs, the circulatory system, respiratory system, and the digestive system; veterinary pharmaceutical substances for the treatment of dermatological diseases, allergies and urogenital or anal conditions; sanitary preparations for medical use; anti-inflammatory agents, namely, topical preparations in the form of gels and salves, adhesive skin patches, liquid formulations, cream and sprays, all for relieving pain
Classification
International Classes
005